Charles River Laboratories International, Inc.
corporate_fare Company Profile
Charles River Laboratories International, Inc. (NYSE:CRL) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 22 items for CRL at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-09, rated 8/10. Across its 20 most recent items scored 7 or higher, the top rating is 9/10, with 17 rated 8 or above. Recent SEC coverage for CRL spans 10-Q, 8-K, DEF 14A, 10-K.
Recent high-impact activity:
- Charles River Bolsters CRO Services With Frontage Bioanalysis, DMPK Buy
- Charles River 10-Q: Q3 Net Income Jumps to $333.1M on $201M Tax Benefit; Create the Future Targets $300M Savings
- Charles River Beats Q3, Raises 2026 Guidance; Non-GAAP EPS Up 27.2%
- Charles River Beats Q3, Lifts 2026 Guidance as Non-GAAP EPS Jumps 27%
- Charles River Reaffirms 2026 Guidance at Upper End, Sets 2030 Targets
Financial Snapshot
Short Interest & Short Volume
2.23 days to coverFINRA reported short interest of 2,987,094 shares in CRL as of the October 30, 2026 settlement, a 5.4% increase from the prior period — about 2.2 days to cover at its recent average daily volume. On November 20, 2026, 49.2% of CRL volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.